Is AXGN Worth Buying in 2026?

Axogen, Inc. Common Stock

STOCK ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Updated 2026-04-19

Here’s whether Axogen, Inc. Common Stock (AXGN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +147.1%; 3-month momentum positive (+24.1%); rising volume confirms the move (1.22x 30d avg). Currently 3.7% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

AXGN is in a confirmed uptrend, trading above both its 50-day ($32.74) and 200-day ($24.42) moving averages. An RSI of 69.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +147.1% compares to +35.1% for SPY (beat the market by 112.0%).

$10,000 invested 1 year ago → $24,711 today
vs. S&P 500 (SPY) — same period beat market by 112.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($24.42)
Above 50-day MA ($32.74)
RSI(14) neutral zone (30–70) — currently 69.8
Positive return (+147.1%)
Within 10% of period high (−3.7%)
Period Range $38.50
$9.22 $39.99
RSI (14) 69.8
0 · OversoldOverbought · 100

Key Metrics

Price$38.50
Period Return+147.1%
Period High$39.99
Period Low$9.22
Drawdown−3.7%
MA-50$32.74
MA-200$24.42
RSI (14)69.8
Avg Volume (30d)1.0M
vs. SPYbeat by 112.0%
Return Rank#140 of 996

Trade AXGN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers